PubMed · 1998 · 21 citations · 0 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular OncologyCancer GlycobiologyChemotherapy ResistanceDrug ResistanceTherapeutic ResistanceAnticancer Drug ResistanceCell Line Sensitivity ProfilingDensitometric AnalysisGanglioside BiosynthesisGanglioside CompositionTherapeutic Drug ResistanceTherapeutic Resistance MechanismsTumor Resistance
Previously we established cell lines resistant to Adriamycin and cisplatin to elucidate the mechanisms involved in acquired drug-resistance. In this study, we investigated ganglioside composition in drug-resistant cell lines. The Adriamycin-resistant cell line, SBC-3/ADM100, exhibited a ganglioside composition ratio similar to that of the parent SBC-3 cells. Densitometric analysis by resorcinol showed a 1.61-fold increase of ganglioside GM2 in SBC-3/ADM100 cells, when compared to the parent SBC-3 cells. The cisplatin-resistant cell line, SBC-3/CDDP, showed a simplified ganglioside pattern, expressing only gangliosides GM3 and GM2. SBC-3/CDDP cells showed a marked increase in ganglioside GM3. These findings suggest that the alteration of ganglioside composition may be actively involved in the acquisition of drug-resistance.